Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
UroGen Pharma
AddedFeb 20, 2024
UpdatedJun 18, 2026
UroGen Pharma

UroGen Pharma

Public

UroGen Pharma Ltd.: A clinical-stage biopharmaceutical firm innovating therapies for uro-oncology.

HQ
New York City, NY, US
Founded
2004
Overview
Compare
Fundraising
Employees
Website

Founded as a clinical-stage biopharmaceutical company, UroGen Pharma Ltd. is dedicated to developing innovative therapies aimed at transforming the standard of care for urological pathologies, with a particular focus on uro-oncology. The company's mission is to elevate treatment options for individuals with urological cancers through breakthrough technologies and transformative therapies. UroGen's product pipeline includes novel drug delivery systems and treatments designed to address unmet medical needs in the field of urology.

UroGen Pharma has garnered attention from notable investors and industry leaders, contributing to its growth and development. The company has achieved significant milestones, including successful public offerings and advancements in clinical trials. UroGen's impact is evident in its commitment to pioneering new possibilities for patients, ultimately aiming to improve outcomes and quality of life for those affected by urological cancers.

UroGen Pharma - Similar Companies

Uro-1 logo

Uro-1

uro1medical.com

Urogpo logo

Urogpo

Urica Therapeutics logo

Urica Therapeutics

Bright Uro logo

Bright Uro

brighturo.com

Royalty Pharma logo

Royalty Pharma

royaltypharma.com

Aytu BioPharma logo

Aytu BioPharma

aytubio.com

Onchilles Pharma logo

Onchilles Pharma

Umoja Biopharma logo

Umoja Biopharma

Aurion Biotech logo

Aurion Biotech

aurionbiotech.com

OncXerna Therapeutics logo

OncXerna Therapeutics

oncxerna.com

Zenopharm logo

Zenopharm

Innocrin Pharmaceuticals logo

Innocrin Pharmaceuticals

innocrinpharma.com

Cullinan Oncology logo

Cullinan Oncology

NextCure logo

NextCure

nextcure.com

MBC Pharma logo

MBC Pharma

mbcpharma.com

UroGen Pharma - Quick Facts

Who are UroGen Pharma's competitors?

Companies similar to UroGen Pharma include Uro-1, Urogpo, Urica Therapeutics and Bright Uro.

When was UroGen Pharma founded?

UroGen Pharma was founded in 2004.

Where is UroGen Pharma's headquarters located?

UroGen Pharma's headquarters is located in New York City, NY, US.

When was UroGen Pharma's last funding round?

UroGen Pharma's most recent funding round was for $100M (USD) in March 2022.

How much has UroGen Pharma raised to-date?

As of Mar 8, 2022, UroGen Pharma has raised a total of $422.1M (USD).

How many employees does UroGen Pharma have?

UroGen Pharma has 200 employees as of Feb 5, 2024.

UroGen Pharma - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthtech
Unique IDs
  • ein: 000000000
  • secCik: 0001668243
  • ticker: URGN
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research